Results 221 to 230 of about 1,444,385 (351)
Germline targeted next-generation sequencing in patients with adrenal incidentalomas. [PDF]
Messina E +16 more
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
In vivo tracking of transfused platelets by next-generation sequencing of mitochondrial DNA. [PDF]
Choi SJ +7 more
europepmc +1 more source
SMN1 copy‐number and sequence variant analysis from next‐generation sequencing data [PDF]
Daniel López-López +8 more
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Next generation sequencing as a panacea for antibiotic susceptibility testing: yea or nay? [PDF]
van Belkum A.
europepmc +1 more source
Usefulness of next-generation sequencing for laboratory diagnosis of rickettsiosis
Fanfan Xing +7 more
openalex +1 more source
Daniel E. Deatherage, Jeffrey E. Barrick
semanticscholar +1 more source

